Effect of Treatment of Low Anterior Resection Syndrome After Rectal Cancer Surgery
Primary Purpose
Low Anterior Resection Syndrome
Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Transanal irrigation
Medication
Sponsored by

About this trial
This is an interventional treatment trial for Low Anterior Resection Syndrome
Eligibility Criteria
Inclusion Criteria:
- Patients that have undergone surgery for rectal cancer (sphincter saving surgery, low anterior resection)
- Adult ≥ 18 years old
- Have scoring major LARS (according to the Low anterior resection syndrome score)
Exclusion Criteria:
- stoma
- recurrent disease
- Another colorectal surgery
- Inflammatory bowel disease (IBD)
Sites / Locations
- Danderyd Hospital
- Karolinska University Hospital
- Stockholm South General Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Transanal irrigation
Medication
Arm Description
Manual transanal irrigation to control bowel function.
Medication to control bowel function.
Outcomes
Primary Outcome Measures
Bowel function
Cleveland incontinence questionnaire
Bowel function, Low anterior resection syndrome (LARS)
Assessed using LARS questionnaire (score 0-42, a high score indicates poor bowel function)
Secondary Outcome Measures
Quality of Life (QoL)
Assessed using EORTC Quality of life questionnaire (QLQ)-C30
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03215017
Brief Title
Effect of Treatment of Low Anterior Resection Syndrome After Rectal Cancer Surgery
Official Title
A Randomized Controlled Study of the Effect of Treatment of Low Anterior Resection Syndrome (LARS) After Rectal Cancer Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
May 15, 2017 (Actual)
Primary Completion Date
December 1, 2022 (Actual)
Study Completion Date
December 1, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Mirna Abraham-Nordling
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
A randomized controlled trial (RCT) in patients who underwent sphincter preserving surgery due to rectal cancer. The study will analyze the effect of Transanal irrigation (TAI) and medication that can help control of the bowel movement in patients with low anterior resection syndrome.
Detailed Description
A randomized controlled trial (RCT) in patients who underwent sphincter preserving surgery due to rectal cancer.
The study will analyze the effect of Transanal irrigation (TAI) and medication that can help control of the bowel movement in patients with low anterior resection syndrome.
An interim analysis will be made after 40 included patients in the study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Anterior Resection Syndrome
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
45 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Transanal irrigation
Arm Type
Experimental
Arm Description
Manual transanal irrigation to control bowel function.
Arm Title
Medication
Arm Type
Active Comparator
Arm Description
Medication to control bowel function.
Intervention Type
Device
Intervention Name(s)
Transanal irrigation
Other Intervention Name(s)
Peristeen® anal irrigation system - Coloplast
Intervention Description
Effect of Transanal irrigation (TAI) using Peristeen® anal irrigation system - Coloplast
Intervention Type
Drug
Intervention Name(s)
Medication
Other Intervention Name(s)
One or a combination of Loperamide, Sorbitol, Sterculia gum
Intervention Description
Medication to help control of the bowel movement (One or a combination of Loperamide, Sorbitol, Sterculia gum)
Primary Outcome Measure Information:
Title
Bowel function
Description
Cleveland incontinence questionnaire
Time Frame
1 year
Title
Bowel function, Low anterior resection syndrome (LARS)
Description
Assessed using LARS questionnaire (score 0-42, a high score indicates poor bowel function)
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Quality of Life (QoL)
Description
Assessed using EORTC Quality of life questionnaire (QLQ)-C30
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients that have undergone surgery for rectal cancer (sphincter saving surgery, low anterior resection)
Adult ≥ 18 years old
Have scoring major LARS (according to the Low anterior resection syndrome score)
Exclusion Criteria:
stoma
recurrent disease
Another colorectal surgery
Inflammatory bowel disease (IBD)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mirna Abraham-Nordling, MD.PhD
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Danderyd Hospital
City
Stockholm
Country
Sweden
Facility Name
Karolinska University Hospital
City
Stockholm
Country
Sweden
Facility Name
Stockholm South General Hospital
City
Stockholm
Country
Sweden
12. IPD Sharing Statement
Citations:
PubMed Identifier
35797618
Citation
Pieniowski EHA, Bergstrom CM, Nordenvall CAM, Westberg KS, Johar AM, Tumlin Ekelund SF, Larsson KR, Pekkari KJ, Jansson Palmer GC, Lagergren P, Abraham-Nordling M. A Randomized Controlled Clinical Trial of Transanal Irrigation Versus Conservative Treatment in Patients With Low Anterior Resection Syndrome After Rectal Cancer Surgery. Ann Surg. 2023 Jan 1;277(1):30-37. doi: 10.1097/SLA.0000000000005482. Epub 2022 Jul 7.
Results Reference
background
Learn more about this trial
Effect of Treatment of Low Anterior Resection Syndrome After Rectal Cancer Surgery
We'll reach out to this number within 24 hrs